Back to FGEN Stock Lookup

FibroGen (FGEN) – PRNewswire

Nov 27, 2020 02:02 AM Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis
Oct 2, 2020 07:00 AM New Ventures Funds Rebrands as Scientia Ventures
May 20, 2020 10:00 PM European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat
Jan 30, 2020 12:01 AM Astellas Submits Supplemental New Drug Application for Approval of Evrenzo® (roxadustat) for the Treatment of Anemia Associated with Chronic Kidney Disease in Non-Dialysis Dependent Patients in Japan
Sep 20, 2019 03:00 AM Evrenzo® (roxadustat) Tablets Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients

Back to FGEN Stock Lookup